QCI Interpret for Oncology

Going beyond: Molecular evidence for off-label therapy use

136 views June 02, 2021

Kathryn Bungartz, Ph.D., Associate StaffField Application Scientist, QIAGEN Digital...

QCI Interpret for Oncology

Expert insights to advance NGS oncology profiling

254 views March 15, 2021

Recently, GenomeWeb and Qiagen partnered on a survey that allowed participants to...

QCI Interpret for Oncology

QCI Interpret One: Oncology variant interpretation just got more precise

889 views June 12, 2020

Competing to offer a comprehensive genomic profiling service for solid or hematology...

QCI Interpret for Oncology

Reduce your test turnaround for large cancer panels

329 views January 02, 2020

Speaker: Sheryl Elkin, CSO, QDI, QIAGEN Interested in learning more? Click here

QCI Interpret for Oncology

Managing multiple biomarker therapeutic development

356 views September 12, 2019

For the past two decades, the paradigm in the field has been “one biomarker, one drug,”...

QCI Interpret for Oncology

Precision medicine for any cancer assay on any platform

930 views May 29, 2019

For NGS cancer testing, keeping pace with new discoveries is a serious bottleneck....